Specify a stock or a cryptocurrency in the search bar to get a summary
Cabio Biotech Wuhan Co Ltd
688089Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People's Republic of China. Address: No. 999 high-tech Avenue, Wuhan, China, 430073
Analytics
WallStreet Target Price
122.88 CNYP/E ratio
30.7647Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688089
Dividend Analytics 688089
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
38 %Dividend History 688089
Stock Valuation 688089
Financials 688089
Results | 2019 | Dynamics |